Why the study?
Does a detectable highly sensitive cardiac troponin I level predict increased long-term mortality in patients with acute pulmonary embolism?
Does a detectable highly sensitive cardiac troponin I level predict increased long-term mortality in patients with acute pulmonary embolism?
In patients with acute pulmonary embolism, a detectable highly sensitive cardiac troponin I level predicts increased long-term mortality, particularly in those identified as low clinical risk.
Answers are grounded in this paper and cite their sources.
Detectable cTnI may identify higher long-term mortality risk after acute PE; leaves open whether it refines existing prognostic models.
BACKGROUND: In patients with acute pulmonary embolism (PE), detectable levels of cardiac troponin I (cTnI) using a highly sensitive assay have been associated with increased in-hospital mortality. We sought to investigate the impact of detectable cTnI on long-term survival following acute PE. HYPOTHESIS: Detectable cTnI levels in patients presenting with acute PE predict increased long-term mortality following hospital discharge. METHODS: In a retrospective cohort study, we analyzed consecutive patients with confirmed acute PE and cTnI assay available from the index hospitalization. The detectable cTnI level was ≥0.012 ng/mL. Patients were classified into low and high clinical risk groups according to the Pulmonary Embolism Severity Index (PESI) at presentation. Subjects were followed for all-cause mortality subsequent to hospital discharge using chart review and Social Security Death Index. RESULTS: A cohort of 289 acute PE patients (mean age 56 years, 51% men), of whom 152 (53%) had a detectable cTnI, was followed for a mean of 3.1 ± 1.8 years after hospital discharge. A total of 71 deaths were observed; 44 (29%) and 27 (20%) in the detectable and undetectable cTnI groups, respectively (P = 0.05). Detectable cTnI was predictive of long-term survival among low-risk (P = 0.009) but not high-risk patients (P = 0.78) who had high mortality rates irrespective of cTnI status. CONCLUSIONS: In patients with acute PE, detectable cTnI is predictive of long-term mortality, particularly among patients who were identified as low risk according to PESI score.
No takes yet. Share an insight, caveat, or question.
Chuy et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: